Levodopa, a drug commonly prescribed for the treatment of Parkinson's disease that increases dopamine in the brain was found to reverse the effects of neuroinflammation on the reward system and improve symptoms associated with depression.
A new gel that contains levodopa can adhere to nasal tissue. The gel releases levodopa directly into the blood and brain. Researchers say the preliminary data reveals the gel has proven to be effective in animal models.
Involuntary movements and tremors caused as a result of taking dopamine replacement medications for Parkinson's disease can be alleviated through the suppression of RasGRP1.
Study provides first concrete examples of how the microbiome can interfere with a drug's intended path throughout the body.
Researchers report a causal link between dopamine, musical pleasure and motivation. Phamacologically manipulating dopamine levels, researchers found increasing dopamine increased the hedonic experience and motivational response to listening to a piece of music.
A new study reveals how bacteria in the gut is able to metabolize levodopa into dopamine in Parkinson's patients.
Researchers pay tribute to Arvid Carlsson, who was awarded the Nobel Prize for his research into dopamine, and evaluate what his research means to modern neuroscience.
A new study reports Parkinson's patients who take dopamine agonists are more likely to develop impulse control disorders.
Researchers have developed a new mathematical algorithm that can detect dyskinesia in Parkinson's patients.
A new study reveals people with Parkinson's disease face a higher risk of developing melanoma skin cancer, and vice versa, than those without the diseases. Parkinson's patients were 4 times more likely to develop skin cancer than those without the movement impairing disease. Additionally, people diagnosed with melanoma were at a fourfold risk of developing Parkinson's.
